Impaired awareness of hypoglycemia remains an issue even in the era of modern technologies, as patients with type 1 diabetes (T1DM) face stricter requirements for glycemic targets. The evaluation of hypoglycemia awareness can be accomplished using questionnaires (Clarke and Gold scores) in combination with clinical appearance and sensor data. A 45-year-old man with T1DM was referred to our clinic in July 2019 due to impaired hypoglycemia awareness and repeated severe hypoglycemic episodes resulting in unconsciousness. At that time, he was driving both a car and a motorcycle. Despite good compliance, increased target values and implementation of continuous glucose monitoring (CGM) with alarms, prolonged hypoglycemias were not eliminated. Therefore, the patient was referred for pancreatic islet transplantation, but he decided not to undergo. In May 2021, his driving license was suspended, which eventually led him to accept treatment with a hybrid closed-loop insulin pump (AID). Shortly after initiation, he achieved satisfactory glycemic control, reduced time spent in hypoglycemia, and had no severe hypoglycemic episodes. According to the questionnaires, the hypoglycemia awareness has improved and his driving license was reinstated. This case study highlights the critical importance of identifying impaired awareness of hypoglycemia, its potential social impacts, and the opportunities for using new technologies to reverse this complication.

3rd Department of Internal Medicine General University Hospital and 1st Faculty of Medicine Charles University Prague Czechia

Zobrazit více v PubMed

American Diabetes Association Professional Practice Committee . 6. Glycemic goals and hypoglycemia: standards of care in diabetes-2024. Diabetes Care. (2024) 47. doi: 10.2337/dc24-S006 PubMed DOI PMC

Farrell CM, McCrimmon RJ. Clinical approaches to treat impaired awareness of hypoglycaemia. Ther. Adv. Endocrinol. Metab. (2021) 12:20420188211000248. doi: 10.1177/20420188211000248 PubMed DOI PMC

Burckhardt MA, Abraham MB, Dart J, Smith GJ, Paramalingam N, O’Dea J, et al. . Impact of hybrid closed loop therapy on hypoglycemia awareness in individuals with type 1 diabetes and impaired hypoglycemia awareness. Diabetes Technol. Ther. (2021) 23:482–90. doi: 10.1089/dia.2020.0517 PubMed DOI

Flatt AJ, Chen E, Peleckis AJ, Dalton-Bakes C, Nguyen HL, Collins HW, et al. . Automated insulin delivery for hypoglycemia avoidance and glucose counterregulation in long-standing type 1 diabetes with hypoglycemia unawareness. Diabetes Technol. Ther. (2023) 25:330–8. doi: 10.1089/dia.2022.0240 PubMed DOI PMC

Lucidi P, Porcellati F, Bolli GB, Fanelli CG. Prevention and management of severe hypoglycemia and hypoglycemia unawareness: incorporating sensor technology. Curr. Diabetes Rep. (2018) 18:83. doi: 10.1007/s11892-018-1042-4 PubMed DOI

Malone SK, Matus AM, Flatt AJ, Peleckis AJ, Grunin L, Yu G, et al. . Prolonged use of an automated insulin delivery system improves sleep in long-standing type 1 diabetes complicated by impaired awareness of hypoglycemia. J. Diabetes Sci. Technol. (2023) 14:19322968231182406. doi: 10.1177/19322968231182406 PubMed DOI PMC

Sherr JL, Laffel LM, Liu J, Wolf W, Bispham J, Chapman KS, et al. . Severe hypoglycemia and impaired awareness of hypoglycemia persist in people with type 1 diabetes despite use of diabetes technology: results from a cross-sectional survey. Diabetes Care. (2024) 47:941–7. doi: 10.2337/dc23-1416 PubMed DOI PMC

Heinemann L, Freckmann G, Ehrmann D, Faber-Heinemann G, Guerra S, Waldenmaier D, et al. . Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Lancet. (2018) 391:1367–77. doi: 10.1016/S0140-6736(18)30297-6 PubMed DOI

Lablanche S, Vantyghem MC, Kessler L, Wojtusciszyn A, Borot S, Thivolet C, et al. . Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol. (2018) 6:527–37. doi: 10.1016/S2213-8587(18)30098-7 PubMed DOI

American Diabetes Association; Lorber, D. Anderson J, Arent S, Cox DJ, Frier BM, Greene MA, et al. . Diabetes and driving. Diabetes Care. (2014) 37. doi: 10.2337/dc14-S097 PubMed DOI